+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Metastatic Breast Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Anaplastic Thyroid Cancer Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Anaplastic Thyroid Cancer Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 90 Pages
  • Global
From
Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 70 Pages
  • Global
From
Hyperphosphatemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Chronic Thromboembolic Pulmonary Hypertension Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Chronic Thromboembolic Pulmonary Hypertension Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 96 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
Acute Ischemic Stroke Diagnosis and Treatment - Global Strategic Business Report - Product Thumbnail Image

Acute Ischemic Stroke Diagnosis and Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 734 Pages
  • Global
From
Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions - Product Thumbnail Image

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

  • Report
  • December 2023
  • 799 Pages
  • Global
From
Myelodysplastic Syndrome (MDS) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Myelodysplastic Syndrome (MDS) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • March 2021
  • 102 Pages
  • Global
From
Acute Ischemic Stroke Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Acute Ischemic Stroke Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 117 Pages
  • Global
From
Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 243 Pages
  • Global
From
Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 354 Pages
  • Global
From
Nivolumab Global Market Report 2024 - Product Thumbnail Image

Nivolumab Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Rubella (German Measles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Rubella (German Measles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 39 Pages
  • Global
From
Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 113 Pages
  • Global
From
Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 383 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 507 Pages
  • Global
From
Bacterial Pneumonia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Bacterial Pneumonia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 87 Pages
  • Global
From
Loading Indicator